Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07179328Phase 1Recruiting
Phase 1, open-label, single-arm trial, sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Safety of Focused Ultrasound-Mediated BBB Disruption at 2 years. Started Jun 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07179328.